Literature DB >> 14566650

Phenotypic variability in three carriers from a family with choroideremia and a frameshift mutation 1388delCCinsG in the REP-1 gene.

Günther Rudolph1, Markus Preising, Petros Kalpadakis, Christos Haritoglou, Gabriele E Lang, Birgit Lorenz.   

Abstract

PURPOSE: To perform genotype-phenotype correlations in a family with choroideremia.
METHODS: A three-generation family with two affected males and five carriers was the subject of the study. Molecular genetic analysis using single-strand conformation polymorphism analysis (SSCP) was conducted in all subjects, while electroretinography (ERG), multifocal ERG (mfERG), scanning laser ophthalmoscope microperimetry (SLO perimetry), fluorescein angiography, and Arden contrast color testing were performed in one male and three carriers.
RESULTS: The findings in the affected male were typical for advanced choroideremia. The three carriers demonstrated a variable clinical phenotype including reduction of visual acuity and ERG and angiographic changes in one. Molecular genetic analysis revealed a functional null mutation (1388delCCinsG) in the REP-1 gene.
CONCLUSIONS: A severe retinal pathology was found in the affected male, indicating that the 1388delCCinsG is a severe mutation. Varying phenotypes were present in the three carriers examined. The phenotype in carriers has been explained by random X-inactivation with varying expression of the inactivated and activated gene copy inside the same cell of both the retinal pigment epithelium and the rods. This thesis is in agreement with the clinical data obtained here.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14566650     DOI: 10.1076/opge.24.4.203.17232

Source DB:  PubMed          Journal:  Ophthalmic Genet        ISSN: 1381-6810            Impact factor:   1.803


  10 in total

1.  Spectrum of Disease Severity and Phenotype in Choroideremia Carriers.

Authors:  Ruben Jauregui; Karen Sophia Park; Akemi J Tanaka; Ahra Cho; Maarjaliis Paavo; Jana Zernant; Jasmine H Francis; Rando Allikmets; Janet R Sparrow; Stephen H Tsang
Journal:  Am J Ophthalmol       Date:  2019-06-08       Impact factor: 5.258

2.  PHENOTYPING CHOROIDEREMIA AND ITS CARRIER STATE WITH MULTIMODAL IMAGING TECHNIQUES.

Authors:  Kevin K Ma; James Lin; Katherine Boudreault; Royce W S Chen; Stephen H Tsang
Journal:  Retin Cases Brief Rep       Date:  2017 Winter

3.  Clinical characteristics of a large choroideremia pedigree carrying a novel CHM mutation.

Authors:  Alex S Huang; Leo A Kim; Amani A Fawzi
Journal:  Arch Ophthalmol       Date:  2012-09

4.  Independent degeneration of photoreceptors and retinal pigment epithelium in conditional knockout mouse models of choroideremia.

Authors:  Tanya Tolmachova; Ross Anders; Magnus Abrink; Laurence Bugeon; Margaret J Dallman; Clare E Futter; José S Ramalho; Felix Tonagel; Naoyuki Tanimoto; Mathias W Seeliger; Clare Huxley; Miguel C Seabra
Journal:  J Clin Invest       Date:  2006-01-12       Impact factor: 14.808

5.  Genetic and phenotypic characteristics of three Mainland Chinese families with choroideremia.

Authors:  Qi Zhou; Liang Liu; Fei Xu; Hui Li; Yuri Sergeev; Fangtian Dong; Ruxin Jiang; Ian MacDonald; Ruifang Sui
Journal:  Mol Vis       Date:  2012-02-03       Impact factor: 2.367

6.  Novel CHM mutations identified in Chinese families with Choroideremia.

Authors:  Xue-Bi Cai; Xiu-Feng Huang; Yi Tong; Qin-Kang Lu; Zi-Bing Jin
Journal:  Sci Rep       Date:  2016-10-14       Impact factor: 4.379

7.  Evaluation of amplification refractory mutation system (ARMS) technique for quick and accurate prenatal gene diagnosis of CHM variant in choroideremia.

Authors:  Lisha Yang; Iqra Ijaz; Jingliang Cheng; Chunli Wei; Xiaojun Tan; Md Asaduzzaman Khan; Xiaodong Fu; Junjiang Fu
Journal:  Appl Clin Genet       Date:  2017-12-19

8.  Genetic analysis and clinical phenotype of two Indian families with X-linked choroideremia.

Authors:  Rajani Battu; Nallathambi Jeyabalan; Praveen Murthy; Kavita S Reddy; Jan Sag Schouten; Caroll A Webers
Journal:  Indian J Ophthalmol       Date:  2016-12       Impact factor: 1.848

9.  Pathogenic mechanisms and the prospect of gene therapy for choroideremia.

Authors:  Ioannis S Dimopoulos; Stephanie Chan; Robert E MacLaren; Ian M MacDonald
Journal:  Expert Opin Orphan Drugs       Date:  2015-07-01       Impact factor: 0.694

10.  Prospective deep phenotyping of choroideremia patients using multimodal structure-function approaches.

Authors:  Ahmed M Hagag; Andreas Mitsios; Akshay Narayan; Alessandro Abbouda; Andrew R Webster; Adam M Dubis; Mariya Moosajee
Journal:  Eye (Lond)       Date:  2020-05-28       Impact factor: 3.775

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.